The Food and Drug Administration on Tuesday approved a new generic version of valsartan to alleviate recent shortages of the blood pressure medication following a series of safety recalls.

This combination medication contains a calcium channel blocker and an angiotensin II receptor antagonist, prescribed for high blood pressure (hypertension).

Sarah Edwards is a seasoned legal writer with more than a decade of experience. Edwards has a deep understanding of advanced legal concepts and a knack for conveying complex topics in simple language.

Scientists from the FDA estimate that if 8,000 people took the highest valsartan dose (320 mg) from the recalled batches daily for four years, there may be one additional case of cancer over the ...

Valsartan 20 mg twice daily, titrated to 160 mg twice daily (n = 4090); Captopril 6.25 mg 3 times daily, titrated to captopril 50 mg 3 times daily (n = 4090); Valsartan 20 mg twice daily ...

study [1] show that valsartan 160 mg once daily is safe and effective in older patients with moderate-to-severe systolic hypertension at risk of cardiovascular comorbidity and that adding ...